Feifei Teng
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Immune cells in cancer
Papers in
- Oncology 35
- Cancer Immunotherapy and Biomarkers 22
- Lung Cancer Research Studies 9
- Inflammatory Biomarkers in Disease Prognosis 6
- Pancreatic and Hepatic Oncology Research 4
-
- Lung Cancer Treatments and Mutations 9
- Lung Cancer Diagnosis and Treatment 6
- Co-authors
- Li Kong (9 shared papers)Xiangjiao Meng (8 shared papers)Xin Wang (1 shared paper)Jinming Yu (1 shared paper)Jinming Yu (4 shared papers)Jinming Yu (21 shared papers)Ligang Xing (4 shared papers)Zhaoqin Huang (2 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (4 papers)Cancer Letters (3 papers)Genes & Diseases (3 papers)OncoTargets and Therapy (3 papers)Cancer Biology & Therapy (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Feifei Teng
52 papers receiving 2.4k citations
Feifei Teng's Hit Papers
Peers
Comparison fields: 5 of 97
- Oncology 1.4k
- Immunology 548
- Pulmonary and Respiratory Medicine 462
- Cancer Research 194
- Genetics 94
Countries citing papers authored by Feifei Teng
This map shows the geographic impact of Feifei Teng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Teng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Teng more than expected).
Fields of papers citing papers by Feifei Teng
This network shows the impact of papers produced by Feifei Teng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Teng. The network helps show where Feifei Teng may publish in the future.
Co-authors
The 25 scholars most cited alongside Feifei Teng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PD-L1 expression in human cancers and its association with clinical outcomes Hit paper breakdown → | 2016 | 623 |
| 2 | Predictive biomarkers in PD-1/PD-L1 checkpoint blockade immunotherapy Hit paper breakdown → | 2015 | 333 |
| 3 | 2017 | 191 | |
| 4 | 2015 | 106 | |
| 5 | Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer. | 2015 | 102 |
| 6 | 2015 | 87 | |
| 7 | 2017 | 82 | |
| 8 | 2017 | 74 | |
| 9 | 2021 | 64 | |
| 10 | 2020 | 55 | |
| 11 | 2021 | 53 | |
| 12 | 2017 | 51 | |
| 13 | 2018 | 48 | |
| 14 | 2017 | 46 | |
| 15 | 2016 | 42 | |
| 16 | 2017 | 42 | |
| 17 | 2023 | 42 | |
| 18 | 2016 | 37 | |
| 19 | 2013 | 36 | |
| 20 | 2016 | 32 |
About Feifei Teng
Feifei Teng is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging, Immunology and Molecular Biology, having authored 57 papers that have together received 2.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (22 papers), Lung Cancer Research Studies (9 papers), Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (6 papers), Inflammatory Biomarkers in Disease Prognosis (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), MRI in cancer diagnosis (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (1.4k citations), Immunology (548 citations), Pulmonary and Respiratory Medicine (462 citations), Cancer Research (194 citations) and Genetics (94 citations). Feifei Teng has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Li Kong, Xiangjiao Meng, Xin Wang, Jinming Yu, Jinming Yu, Jinming Yu, Ligang Xing, Zhaoqin Huang, Li Ren Kong and Dianbin Mu. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer Letters, Genes & Diseases, OncoTargets and Therapy and Cancer Biology & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.